Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Kymera Therapeutics Inc., 3 years.
Kymera Therapeutics Inc.
Director
Tectonic Therapeutic Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 13, 2024 | Kymera Therapeutics Inc. | Open-market sale | −8,430 | $34.98 | $294,881 |
| Jun 13, 2024 | Kymera Therapeutics Inc. | Open-market sale | −1,770 | $34.98 | $61,915 |
| Jun 12, 2024 | Kymera Therapeutics Inc. | Open-market sale | −11,838 | $35.35 | $418,473 |
| Jun 12, 2024 | Kymera Therapeutics Inc. | Open-market sale | −1,997 | $36.02 | $71,932 |
| Jun 12, 2024 | Kymera Therapeutics Inc. | Open-market sale | −2,485 | $35.35 | $87,845 |
| Jun 12, 2024 | Kymera Therapeutics Inc. | Open-market sale | −420 | $36.02 | $15,128 |
| Mar 15, 2024 | Kymera Therapeutics Inc. | Open-market sale | −8,126 | $39.31 | $319,433 |
| Mar 15, 2024 | Kymera Therapeutics Inc. | Open-market sale | −49,591 | $40.62 | $2,014,386 |
| Mar 15, 2024 | Kymera Therapeutics Inc. | Open-market sale | −1,593 | $41.23 | $65,679 |
| Mar 15, 2024 | Kymera Therapeutics Inc. | Open-market sale | −1,714 | $39.31 | $67,377 |
| Mar 15, 2024 | Kymera Therapeutics Inc. | Open-market sale | −10,411 | $40.62 | $422,895 |
| Mar 15, 2024 | Kymera Therapeutics Inc. | Open-market sale | −329 | $41.23 | $13,565 |
| Mar 14, 2024 | Kymera Therapeutics Inc. | Open-market sale | −34,473 | $39.73 | $1,369,612 |
| Mar 14, 2024 | Kymera Therapeutics Inc. | Open-market sale | −10,846 | $40.66 | $440,998 |
| Mar 14, 2024 | Kymera Therapeutics Inc. | Open-market sale | −781 | $41.51 | $32,419 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.